Mass spectrometry (MS) has been increasingly used to study central nervous system disorders, including autism spectrum disorders (ASDs). The first studies of ASD using MS focused on the identification of external toxins, but current research is more directed at understanding endogenous protein changes that occur in ASD (ASD proteomics). This chapter focuses on how MS has been used to study ASDs, with particular focus on proteomic analysis. Other neurodevelopmental disorders have been investigated using this technique, including genetic syndromes associated with autism such as fragile X syndrome and Smith–Lemli– Opitz syndrome.
CITATION STYLE
Wetie, A. G. N., Dekroon, R. M., Mocanu, M., Ryan, J. P., Darie, C. C., & Woods, A. G. (2014). Mass spectrometry for the study of autism and neurodevelopmental disorders. Advances in Experimental Medicine and Biology, 806, 525–544. https://doi.org/10.1007/978-3-319-06068-2_26
Mendeley helps you to discover research relevant for your work.